Filter Results :

Your search for Biotech and Diagnostics returned 12 reports

Sort by


Lab Automation Market by Equipment and Software (Robotic Arms, Microplate Readers, LIMS), Applications (Drug Discovery, Clinical Diagnostics, Genomics), End Users (Biotechnology and Pharmaceuticals, Diagnostic Labs) - Global Forecast to 2022

20 Nov 2017  |  Published by:  MarketsandMarkets
The global lab automation market is projected to grow at a CAGR of 5.1%The lab automation market is expected to reach USD 5.20 billion by 2022 from an estimated USD 4.06 billion in 2017, at a CAGR of 5.1%. Factors such as process miniaturization, high demand for lab automation equipment in drug disc...

$ 5,650.00

Read More

Global Option and Evaluation Partnership Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Nov 2017  |  Published by:  CurrentPartnering
The Global Option and Evaluation Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report. This report provides details of the latest option and evaluation agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the...

$ 2,995.00

Read More

Global Asset Purchase Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

01 Nov 2017  |  Published by:  CurrentPartnering
The Global Asset Purchase Deals in Pharma, Biotech and Diagnostics 2010-2017 report provides a detailed understanding and analysis of how and why companies enter business, product, technology and royalty assets. The report provides a detailed understanding and analysis of how and why companies ...

$ 2,995.00

Read More

Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

01 Nov 2017  |  Published by:  CurrentPartnering
The Global Distribution Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides details of the latest distribution agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully revised and updated, the report provides details of dis...

$ 2,995.00

Read More

Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Nov 2017  |  Published by:  CurrentPartnering
The Global Manufacturing and Supply Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report. This report provides details of the latest manufacturing and supply agreements announced in the pharmaceutical, biotechnology, device and diagnostic sectors. Fully revised an...

$ 2,995.00

Read More

Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Joint Venture Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the joint venture partnering agreements entered into by the worlds leading healthcare companies "The Global Joint Venture Part...

$ 1,995.00

Read More

Global Collaborative R&D Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2012-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Collaborative R&D Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the collaborative R&D partnering deals and agreements entered into by the worlds leading healthcare companies ...

$ 2,995.00

Read More

Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Merger and Acquisition Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides details of the latest merger and acquisition (M&A) agreements announced in the pharmaceutical, biotechnology, diagnostic and other lifescience sectors. Fully revised and updated, t...

$ 2,995.00

Read More

Global Co-development Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010 to 2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Co-development Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-development deals and agreements entered into by the worlds leading healthcare companies "The Global Co-development ...

$ 2,995.00

Read More

Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Royalty Financing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the royalty financing partnering agreements entered into by the worlds leading healthcare companies "The Global Royalty Fi...

$ 1,995.00

Read More

Global Co-promotion and Co-marketing Partnering Terms and Agreements in Pharma, Biotech & Diagnostics 2010-2017

01 Sep 2017  |  Published by:  CurrentPartnering
The Global Co-promotion and Co-marketing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2010-2017 report provides comprehensive understanding and unprecedented access to the co-promotion and co-marketing partnering agreements entered into by the worlds leading healthcare comp...

$ 2,995.00

Read More

Stable Isotope Labeled Compounds Market by Type (C13, D, 018, N15 label), Application (Research, Clinical Diagnostics, Industrial), End User (Pharmaceutical and Biotechnology Companies, Academic and Research Institutes, Hospital) - Global Forecast to 2022

26 Jul 2017  |  Published by:  MarketsandMarkets
The stable isotope-labeled compounds market is projected to grow at a CAGR of 2.94%.The global stable isotope-labeled compounds market is estimated to grow at a CAGR of 2.94% from 2017 to 2022, to reach USD 294.2 million by 2022. Increase in research activities in the pharmaceutical and biotechnolog...

$ 5,650.00

Read More
Total 12 records.